参考文献/References:
[1] ZHU H,MA X,YE T,et al.Esophageal cancer in China:Practice and research in the new era[J].Int J Cancer,2023,152(9):1741-1751.
[2] 张广健,李益行,范坤,等.肠功能恢复汤深部保留灌肠对食管癌术后患者肠功能恢复的疗效研究[J].陕西中医,2022,43(11):1560-1562.
[3] WATERS J K,REZNIK S I.Update on management of squamous cell esophageal cancer[J].Curr Oncol Rep,2022,24(3):375-385.
[4] 林晓溪,张俊毅.斑菲素蛋白2在食管鳞状细胞癌组织中的表达及临床意义[J].陕西医学杂志,2022,51(6):741-744.
[5] ISHIHARA R.Endoscopic diagnosis and treatment of superficial esophageal squamous cell cancer:Present status and future perspectives[J].Curr Oncol,2022,29(2):534-543.
[6] KALACHAVEEDU M,SENTHIL R,AZHAGIYAMANAVALAN S,et al.Traditional medicine herbs as natural product matrices in cancer chemoprevention:A trans pharmacological perspective(scoping review)[J].Phytother Res,2023,37(4):1539-1573.
[7] HUANG J,CHANG Z,LU Q,et al.Nobiletin as an inducer of programmed cell death in cancer:A review[J].Apoptosis,2022,27(5-6):297-310.
[8] CHEN Y Y,LIANG J J,WANG D L,et al.Nobiletin as a chemopreventive natural product against cancer,a comprehensive review[J].Crit Rev Food Sci Nutr,2023,63(23):6309-6329.
[9] WANG W,HE Q,ZHUANG C,et al.Apatinib through activating the RhoA/ROCK signaling pathway to cause dysfunction of vascular smooth muscle cells[J].Appl Biochem Biotechnol,2022,194(11):5367-5385.
[10] 张云波,顾申红,陈菊明,等.基于RhoA/ROCK信号通路探讨四逆汤对心肌缺血再灌注氧化损伤作用机制[J].陕西中医,2022,43(3):301-304.
[11] GLOTFELTY E J,TOVAR-Y-ROMO L B,HSUEH S C,et al.The RhoA-ROCK1/ROCK2 pathway exacerbates inflammatory signaling in immortalized and primary microglia[J].Cells,2023,12(10):1367-1397.
[12] 李朝慧,任本洪,孙雪娇,等.顺铂耐药对食管癌细胞增殖、凋亡、迁移和血管生成的影响[J].中国病理生理杂志,2017,33(1):1-6.
[13] 孙嘉伟,卢秀,王燕.川陈皮素调控LINC00116对结直肠癌细胞生物学功能的影响[J].山东医药,2021,61(16):56-60.
[14] LIU C Q,MA Y L,QIN Q,et al.Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040[J].Thorac Cancer,2023,14(1):3-11.
[15] 申丽,李东辉,李杰,等.纳武单抗在硅纤维沉积性食管鳞癌化疗中的效果及安全性研究[J].陕西医学杂志,2023,52(6):732-736.
[16] DAI X,ZHANG X,CHEN W,et al.Dihydroartemisinin:A potential natural anticancer drug[J].Int J Biol Sci,2021,17(2):603-622.
[17] AN J,AN S,CHOI M,et al.Natural products for esophageal cancer therapy:From traditional medicine to modern drug discovery[J].Int J Mol Sci,2022,23(21):13558-13584.
[18] YOU L,LIN J,YU Z,et al.Nobiletin suppresses cholangiocarcinoma proliferation via inhibiting GSK3β[J].Int J Biol Sci,2022,18(15):5698-5712.
[19] ZHANG R,CHEN J,MAO L,et al.Nobiletin triggers reactive oxygen species-mediated pyroptosis through regulating autophagy in ovarian cancer cells[J].J Agric Food Chem,2020,68(5):1326-1336.
[20] SOUSA D P,POJO M,PINTO A T,et al.Nobiletin alone or in combination with cisplatin decreases the viability of anaplastic thyroid cancer cell lines[J].Nutr Cancer,2020,72(2):352-363.
[21] WANG J G,JIAN W J,LI Y,et al.Nobiletin promotes the pyroptosis of breast cancer via regulation of miR-200b/JAZF1 axis[J].Kaohsiung J Med Sci,2021,37(7):572-582.
[22] SUI C,WU Y,ZHANG R,et al.Rutin inhibits the progression of osteoarthritis through CBS-mediated RhoA/ROCK signaling[J].DNA Cell Biol,2022,41(6):617-630.
[23] CHEN H,SHEN D,ZHU F,et al.Long noncoding RNA RP11-89K21.1 interacts with miR-146a/b-5p to promote proliferation and gefitinib resistance through regulating RHPN2 and RhoA/ROCK pathway in lung adenocarcinoma[J].Cancer Biother Radiopharm,2023,38(5):282-292.
[24] 唐军伟,彭洪,郑和平,等.MYPT1通过RhoA/ROCK信号通路抑制结直肠癌细胞增殖和迁移[J].西部医学,2022,34(7):966-972.
[25] 李登辉,蔡润茁,朱丽明,等.lncRNA HOTAIR靶向miR-126激活RhoA/ROCK通路促进喉癌Hep-2细胞增殖、侵袭与EMT[J].现代肿瘤医学,2022,30(3):365-370.
[26] LI X,LI D,MA R.ALW-II-41-27,an EphA2 inhibitor,inhibits proliferation,migration and invasion of cervical cancer cells via inhibition of the RhoA/ROCK pathway[J].Oncol Lett,2022,23(4):129-139.
[27] WEI X,LOU H,ZHOU D,et al.TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA/ROCK pathway[J].J Exp Clin Cancer Res,2021,40(1):292-305.
相似文献/References:
[1]胡珊珊,宋 彦,罗玉明,等.食管内放射支架对中晚期食管癌患者吞咽困难疗效及预后影响[J].陕西医学杂志,2019,(1):83.
HU Shanshan,SONG Yan,LUO Yuming,et al.Effect of esophageal stent on dysphagia and prognosis in patients with advanced esophageal cancer[J].,2019,(3):83.
[2]魏晓华,郭俊霞.不同内镜技术在食管癌及癌前病变筛查中的应用价值研究*[J].陕西医学杂志,2019,(5):591.
WEI Xiaohua,GUO Junxia..Application value of different endoscopy techniques in the screening of esophageal cancer and precancerous lesions[J].,2019,(3):591.
[3]马显平,张海斌.叉头框转录因子M1和增殖细胞核抗原在食管癌组织中的表达及与放化疗预后相关性分析[J].陕西医学杂志,2021,50(9):1150.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.027]
MA Xianping,ZHANG Haibin.Expression of FOXM1 and PCNA in esophageal carcinoma and their correlation with prognosis of radiotherapy and chemotherapy[J].,2021,50(3):1150.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.027]
[4]何 芸,张卫卫,孔祥云.血清白细胞介素-6、肿瘤坏死因子-α、活性氧在食管癌术后并发心房颤动患者体内表达水平及检测意义[J].陕西医学杂志,2022,51(7):816.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.011]
HE Yun,ZHANG Weiwei,KONG Xiangyun.Expression level and significance of serum IL-6,TNF-α and reactive oxygen species in patients with atrial fibrillation after esophageal cancer surgery[J].,2022,51(3):816.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.011]
[5]张新伟,王瑞洁,张 曦,等.帕博利珠单抗联合新辅助化疗治疗Ⅱ、Ⅲ期食管癌临床疗效[J].陕西医学杂志,2022,51(7):870.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.025]
ZHANG Xinwei,WANG Ruijie,ZHANG Xi,et al.Clinical efficacy of pembrolizumab combined with neoadjuvant chemotherapy in treatment of stage Ⅱ and Ⅲ esophageal cancer[J].,2022,51(3):870.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.025]
[6]周 敏,张艳霞,郭 楠,等.甲磺酸阿帕替尼对裸鼠食管癌的抗肿瘤作用及机制研究[J].陕西医学杂志,2023,52(12):1670.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.009]
ZHOU Min,ZHANG Yanxia,GUO Nan,et al.Antitumor effect and mechanism of apatinib mesylate on esophageal cancer in nude mice[J].,2023,52(3):1670.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.009]
[7]易三凤,屈银宗,龚承先,等.环状RNA GRIN2B通过调控微小RNA-135b对食管癌细胞增殖和侵袭的影响实验研究[J].陕西医学杂志,2024,(3):308.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.004]
YI Sanfeng,QU Yinzong,GONG Chengxian,et al.Effects of circular RNA GRIN2B on proliferation and invasion of esophageal cancer cells through regulation of microRNA-135b[J].,2024,(3):308.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.004]
[8]张少锋,李丹青,杜 凡,等.食管癌术后重症肺炎患者血清肺表面活性物质相关蛋白质-D、高迁移率族蛋白B1和中性粒细胞与淋巴细胞比值水平变化及检测意义[J].陕西医学杂志,2024,(8):1114.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.024]
ZHANG Shaofeng,LI Danqing,DU Fan,et al.Changes and detection significance of serum pulmonary surfactant associated protein,high mobility group box 1 protein and neutrophil-to-lymphocyte ratioin patients with severe pneumonia after esophageal cancer surgery[J].,2024,(3):1114.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.024]
[9]符梦婕,张 剑,李秋忆,等.长链非编码RNA淋巴细胞白血病缺失基因2/微小RNA-30c-5p/丝裂原活化蛋白激酶1轴在食管癌细胞紫杉醇耐药中的作用机制实验研究[J].陕西医学杂志,2024,(9):1155.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.001]
FU Mengjie,ZHANG Jian,LI Qiuyi,et al.Mechanism of lncRNA DLEU2/miR-30c-5p/MAPK1 axis in paclitaxel resistance in esophageal cancer cells[J].,2024,(3):1155.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.001]
[10]王银燕,黄 翠,朱 艳,等.长链非编码RNA UBE2Q1-AS1对食管癌细胞增殖和迁移的调节作用及机制实验研究[J].陕西医学杂志,2024,(9):1172.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.004]
WANG Yinyan,HUANG Cui,ZHU Yan,et al.Regulatory effect and mechanism of lncRNA UBE2Q1-AS1 on proliferation and migration of esophageal cancer cells[J].,2024,(3):1172.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.004]